Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Mydecine Innovations Group Inc (MYCOF)

Mydecine Innovations Group Inc (MYCOF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade MYCOF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4003 +44.89%
on 07/19/22
0.7500 -22.67%
on 08/04/22
-0.0800 (-12.12%)
since 07/12/22
3-Month
0.2500 +132.00%
on 05/20/22
1.0900 -46.79%
on 05/13/22
-0.5100 (-46.79%)
since 05/12/22
52-Week
0.0500 +1,060.00%
on 04/18/22
110.0000 -99.47%
on 10/01/21
-18.2300 (-96.92%)
since 08/12/21

Most Recent Stories

More News
MYDECINE INNOVATIONS GROUP ANNOUNCES RESIGNATION OF DIRECTORS

/CNW/ - Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA), a biotechnology company engineering the next wave...

MYCOF : 0.5800 (-15.94%)
Mydecine Files Full Patent Application Covering MYCO-006 Family of Novel Short-Acting MDMA Analogs

Company aims to increase health equity by developing more accessible treatment modalities better suited for existing healthcare infrastructure...

MYCO.NE : 0.770 (unch)
OTC.VN : 0.320 (unch)
MYCOF : 0.5800 (-15.94%)
U.S. FDA Clears MYCO-001 for Multi-Site Government Funded Trial in Smoking Cessation

DENVER, June 17, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology...

MYCO.NE : 0.770 (unch)
OTC.VN : 0.320 (unch)
MYCOF : 0.5800 (-15.94%)
Mydecine Provides Company Update; Welcomes New Board Member

DENVER, June 09, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a...

MYCO.NE : 0.770 (unch)
OTC.VN : 0.320 (unch)
MYCOF : 0.5800 (-15.94%)
Mydecine Overnight Marketed Public Offering of Units

/CNW/ - Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) is pleased to announce that it has commenced an...

MYCOF : 0.5800 (-15.94%)
Mydecine Announces First Quarter 2022 Financial Results and Highlights

DENVER, May 16, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a...

MYCO.NE : 0.770 (unch)
OTC.VN : 0.320 (unch)
MYCOF : 0.5800 (-15.94%)
American Billionaire Entrepreneurs Bet Millions on Psychedelics

FN Media Group Presents Microsmallcap.com Market Commentary   New York, NY – May 10, 2022 – Billionaire Bob Parsons, the founder of GoDaddy, believes psychedelics can heal trauma. The Marine infantryman...

CYBN.NE : 1.020 (-6.42%)
MYCO.NE : 0.770 (unch)
PYPL : 101.10 (+2.01%)
TSLA : 900.09 (+4.68%)
CYBN : 0.8000 (-6.61%)
MYCOF : 0.5800 (-15.94%)
NUMI.TO : 0.3200 (+14.29%)
NUMIF : 0.2495 (+11.53%)
ATAI : 4.58 (+3.39%)
ENVB : 6.69 (-1.33%)
MYDECINE INNOVATIONS GROUP ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT

/CNW/ - Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) is pleased to announce that, in connection with its...

MYCOF : 0.5800 (-15.94%)
MYDECINE INNOVATIONS GROUP FILES PROSPECTUS SUPPLEMENT

/CNW/ - Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) is pleased to announce that in connection with its...

MYCOF : 0.5800 (-15.94%)
Mydecine Announces Reverse Stock-Split

/CNW/ - Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"), today announces its Board of Directors has voted in...

MYCOF : 0.5800 (-15.94%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.6467
2nd Resistance Point 0.6333
1st Resistance Point 0.6067
Last Price 0.5800
1st Support Level 0.5667
2nd Support Level 0.5533
3rd Support Level 0.5267

See More

52-Week High 110.0000
Fibonacci 61.8% 67.9991
Fibonacci 50% 55.0250
Fibonacci 38.2% 42.0509
Last Price 0.5800
52-Week Low 0.0500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar